Literature DB >> 3973823

Endogenous opiate peptides may limit norepinephrine release during hemorrhage.

J C Schadt, R R Gaddis.   

Abstract

The involvement of the sympathetic nervous system in the cardiovascular response to hemorrhage and subsequent opiate receptor blockade was studied in conscious rabbits. Plasma catecholamines were measured by high-pressure liquid chromatography to indirectly assess sympathetic activity. Arterial blood samples were drawn at four times during the experiment: 1) before hemorrhage; 2) after a 15% blood loss; 3) after mean arterial blood pressure decreased to less than 40 mm Hg; and 4) 2 min after an i.v. injection of naloxone (3 mg/kg) or saline. Rapid removal of 15% of the total blood volume (approximately equal to 8 ml/kg) increased heart rate and plasma norepinephrine. Plasma epinephrine and blood pressure remained at control levels. Further hemorrhage (approximately equal to 16 ml/kg) produced a sudden decrease in blood pressure and a large increase in plasma epinephrine. Plasma norepinephrine was not significantly different from the previous sample. Subsequent injection of naloxone significantly increased plasma norepinephrine and blood pressure compared to the saline-treated group. Plasma epinephrine was similar in the two groups. These studies suggest that naloxone may exert its pressor effect during hemorrhagic hypotension in the conscious rabbit by blocking a naturally occurring, opiate peptide-mediated inhibition of norepinephrine release. The results are consistent with a peptidergic limit on sympathetic activity being responsible for the decrease in blood pressure seen during acute hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973823

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Peripheral sympatho-inhibitory cardiovascular effects of opioid peptides in anaesthetized rabbits.

Authors:  B Szabo; L Hedler; C Schurr; K Starke
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

2.  ACTH-(1-24) restores blood pressure in acute hypovolaemia and haemorrhagic shock in humans.

Authors:  A Bertolini; S Guarini; W Ferrari; G Noera; C Massini; S Di Tizio
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Typical vasovagal syncope as a "defense mechanism" for the heart by contrasting sympathetic overactivity.

Authors:  Paolo Alboni; Marco Alboni
Journal:  Clin Auton Res       Date:  2017-07-01       Impact factor: 4.435

4.  Involvement of the sympathetic nervous system in the cardiovascular effects of ACTH-(1-24) during hemorrhagic shock in rats.

Authors:  S Guarini; W Ferrari; A Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

5.  Role of neuronal and vascular Ca(2+)-channels in the ACTH-induced reversal of haemorrhagic shock.

Authors:  S Guarini; C Bazzani; A Bertolini
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

6.  Opioid peptides decrease noradrenaline release and blood pressure in the rabbit at peripheral receptors.

Authors:  B Szabo; L Hedler; H Ensinger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

7.  Changes in plasma catecholamine levels following injection of prostaglandin F2alpha into the basal cistern in rabbits.

Authors:  Y Yokoyama; M Uchida; S Matsumoto; K Saito; M Fukuda
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

8.  Circulating [Met]enkephalin and catecholamine responses to acute hypotension and hypertension in anaesthetized greyhounds.

Authors:  D F Mason; S Medbak; L H Rees
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

9.  Effect of naloxone on haemodynamic responses to acute blood loss in unanaesthetized rabbits.

Authors:  J Ludbrook; P C Rutter
Journal:  J Physiol       Date:  1988-06       Impact factor: 5.182

Review 10.  Vasovagal Syncope As A Manifestation Of An Evolutionary Selected Trait.

Authors:  Paolo Alboni; Marco Alboni
Journal:  J Atr Fibrillation       Date:  2014-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.